Bangolo Ayrton I, Wadhwani Nikita
Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States.
World J Exp Med. 2024 Dec 20;14(4):94845. doi: 10.5493/wjem.v14.i4.94845.
This comprehensive analysis by Saeed and Faeq investigates the impact of primary percutaneous coronary intervention (pPCI) on mortality among patients with ST-segment elevation myocardial infarction (STEMI) at the Erbil Cardiac Center. Analyzing data from 96 consecutive STEMI patients, the study identified significant predictors of in-hospital mortality, emphasizing the critical impact of time of hospital arrival post-symptom onset on overall prognosis. Findings indicate that factors such as atypical presentation, cardiogenic shock, chronic kidney disease, and specific coronary complications are associated with higher mortality rates. The study underscores the necessity of prompt medical intervention for improving survival outcomes in STEMI patients, especially in the high-risk subgroup. This research offers valuable insights into optimizing STEMI management and enhancing patient survival rates through effective and timely pPCI.
赛义德和法伊克的这项综合分析调查了埃尔比勒心脏中心直接经皮冠状动脉介入治疗(pPCI)对ST段抬高型心肌梗死(STEMI)患者死亡率的影响。该研究分析了96例连续STEMI患者的数据,确定了院内死亡的重要预测因素,强调症状发作后到达医院的时间对总体预后的关键影响。研究结果表明,非典型表现、心源性休克、慢性肾病和特定冠状动脉并发症等因素与较高的死亡率相关。该研究强调了及时进行医疗干预以改善STEMI患者生存结果的必要性,特别是在高危亚组中。这项研究为通过有效及时的pPCI优化STEMI管理和提高患者生存率提供了有价值的见解。